awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38338236-18634DE0-A7D6-4226-9D43-CD9F64701F8C
Q38338236-18634DE0-A7D6-4226-9D43-CD9F64701F8C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38338236-18634DE0-A7D6-4226-9D43-CD9F64701F8C
PCSK9 inhibition: current concepts and lessons from human genetics.
P2860
Q38338236-18634DE0-A7D6-4226-9D43-CD9F64701F8C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38338236-18634DE0-A7D6-4226-9D43-CD9F64701F8C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
655e8dcede293aea8500af1fd345ad2fb7078b1d
P2860
Efficacy and safety of alirocumab as add-on therapy in high-cardiovascular-risk patients with hypercholesterolemia not adequately controlled with atorvastatin (20 or 40 mg) or rosuvastatin (10 or 20 mg): design and rationale of the ODYSSEY OPTIONS S